JPWO2022140238A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022140238A5
JPWO2022140238A5 JP2023534653A JP2023534653A JPWO2022140238A5 JP WO2022140238 A5 JPWO2022140238 A5 JP WO2022140238A5 JP 2023534653 A JP2023534653 A JP 2023534653A JP 2023534653 A JP2023534653 A JP 2023534653A JP WO2022140238 A5 JPWO2022140238 A5 JP WO2022140238A5
Authority
JP
Japan
Prior art keywords
optionally substituted
cell
independently
sulfur
nitrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023534653A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024503976A (ja
JP2024503976A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/064312 external-priority patent/WO2022140238A1/en
Publication of JP2024503976A publication Critical patent/JP2024503976A/ja
Publication of JP2024503976A5 publication Critical patent/JP2024503976A5/ja
Publication of JPWO2022140238A5 publication Critical patent/JPWO2022140238A5/ja
Pending legal-status Critical Current

Links

JP2023534653A 2020-12-21 2021-12-20 アセタールを含むナノ材料 Pending JP2024503976A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063128682P 2020-12-21 2020-12-21
US63/128,682 2020-12-21
PCT/US2021/064312 WO2022140238A1 (en) 2020-12-21 2021-12-20 Nanomaterials comprising acetals

Publications (3)

Publication Number Publication Date
JP2024503976A JP2024503976A (ja) 2024-01-30
JP2024503976A5 JP2024503976A5 (https=) 2024-12-27
JPWO2022140238A5 true JPWO2022140238A5 (https=) 2024-12-27

Family

ID=82158389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023534653A Pending JP2024503976A (ja) 2020-12-21 2021-12-20 アセタールを含むナノ材料

Country Status (7)

Country Link
US (1) US20230331656A1 (https=)
EP (1) EP4262817A4 (https=)
JP (1) JP2024503976A (https=)
CN (1) CN116782913A (https=)
AU (1) AU2021409377A1 (https=)
CA (1) CA3203457A1 (https=)
WO (1) WO2022140238A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12569438B2 (en) 2019-07-29 2026-03-10 Georgia Tech Research Corporation Nanomaterials containing constrained lipids and uses thereof
US12435035B2 (en) 2020-01-09 2025-10-07 Guide Therapeutics, Llc Nanomaterials
IL303845A (en) 2021-01-20 2023-08-01 Beam Therapeutics Inc Nanomaterials include a degradable property
KR20230131863A (ko) 2021-01-20 2023-09-14 빔 테라퓨틱스, 인크. 나노물질
WO2024019936A1 (en) 2022-07-20 2024-01-25 Beam Therapeutics Inc. Nanomaterials comprising triols
US12311033B2 (en) 2023-05-31 2025-05-27 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3622993A1 (de) * 1986-07-09 1988-01-21 Behringwerke Ag Dispersionspolymere, biologisch aktive dispersionspolymere, verfahren zu ihrer herstellung und verwendung als diagnostisches mittel
DE19940641A1 (de) * 1999-08-26 2001-03-01 Basf Ag Verfahren zur Herstellung von 4-Acyl-aminosäureestern und N-Acyl-Aminoacetalen
US20080039531A1 (en) * 2005-06-13 2008-02-14 Alfred Stracher Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders
JP5422357B2 (ja) * 2008-12-12 2014-02-19 富士フイルム株式会社 感活性光線性又は感放射線性樹脂組成物、及びそれを用いたパターン形成方法
WO2020072605A1 (en) * 2018-10-02 2020-04-09 Intellia Therapeutics, Inc. Ionizable amine lipids
WO2020219876A1 (en) * 2019-04-25 2020-10-29 Intellia Therapeutics, Inc. Ionizable amine lipids and lipid nanoparticles
MX2023007137A (es) * 2020-12-21 2023-08-28 Beam Therapeutics Inc Nanomateriales que comprenden acetales unidos a ésteres.

Similar Documents

Publication Publication Date Title
JPWO2022140252A5 (https=)
TWI867455B (zh) 用於治療病毒感染的化合物及方法
JP7559223B2 (ja) リン脂質化合物及びその使用
US20250064750A1 (en) Lipid and composition used for delivery
JP2017510663A (ja) Mertk特異的ピリミジン化合物
JP7479384B2 (ja) N-複素環式5員環含有カプシドタンパク質のアセンブリの阻害剤、その医薬組成物および使用
JP2025148464A (ja) 三環式pde3/pde4二重阻害剤化合物の医薬組成物
US10538482B2 (en) Adamantane and memantine derivatives as peripheral NMDA receptor antagonists
CA3193340A1 (en) Tes-based cationic lipids
JPWO2022140238A5 (https=)
US20230285381A1 (en) Novel dizocilpine derivatives as peripheral nmda receptor antagonists
JPWO2022159472A5 (https=)
JPWO2022159475A5 (https=)
US11390613B2 (en) Azole analogues and methods of use thereof
JPWO2023121971A5 (https=)
JPWO2023121975A5 (https=)
KR20230143611A (ko) 바이사이클릭 고리를 포함하는 tyk2 억제제 화합물
JPWO2022159421A5 (https=)
JPWO2022159463A5 (https=)
JP2026500527A (ja) 脂質化合物ならびにその製造方法及び使用方法
TW202408503A (zh) 治療纖維化之方法
JP2024527541A (ja) Mrnaの送達のための組成物
KR20230058112A (ko) Ssao 억제제의 다형체
CN114828830A (zh) 药物组合物及处置剂
CN113861178B (zh) 一类噁二唑类化合物及其制备方法、药物组合物和用途